Aarti Pharmalabs share price target

This article concerns share price targets for the next 10 to 15 years based on technical analysis, fundamental goals, and past performance. The estimated Aarti Pharmalabs share price target 2024 to 2030, and 2035 are shown below.

Overview

Aarti Pharmalabs is a leading manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, new chemical entities, and xanthine derivatives. Aarti Pharmalabs is a part of Aarti Industries, incorporated in 1984, and headquartered in Mumbai, Maharashtra, India. In the initial years, it was focused on the chemical sector; later in 2000, it started expanding manufacturing of pharmaceutical APIs; this year was marked as a notable growth period for the company.

Aarti Pharmalabs share price target 2024 to 2030 and 2035

Aarti Pharmalabs Share Price Targets are: 2024 – 783.60 to 805.55, 2025 – 1044 to 1196, 2026 – 1268 to 1365, 2027 – 1489 to 1574, 2028 – 1666 to 1732, 2029 – 1875 to 2005, 2030 – 2239 to 2348 and price forecasted 4586 to 4988 by 2035.

Aarti Pharmalabs share price target 2024

The NSE (National Stock Exchange) and BSE (Bombay Stock Exchange) listed Aarti Pharmalabs under the symbol AARTIPHARM. The company’s closing share price as of September 27, 2024, was 615.90. It is not a fixed share price; fluctuation happens every second in the open market.

Aarti Pharmalabs share price is recently above the 20 and 50-day moving averages. It’s in a bullish trend, best considered for a positional buy; 650 was the strong resistance in the previous few days. The share price may rise after crossing the 650-700 zone in the upcoming days. 

Aarti Pharmalabs share price target 2024 is 783.60 as the first target and 805.55 as the second target

Aarti Pharmalabs share price target 2025

The company’s Active Pharmaceutical Ingredients (API) manufacturing facility in Maharashtra includes production blocks for generic API, corticosteroids, and oncology API, all of which are US FDA and EU GMP accredited. In the API area, it generates the fundamental raw materials for goods, allowing the company to preserve a strong position. It is also a favored partner in regulated markets since it provides regulatory documentation and intellectual property support for worldwide markets (20 CEPs and 40 USDMFs).

Aarti Pharmalabs initial forecasted share value for the beginning of the year 2025 is 951. The semi-annual price forecast may rise to 1044 in a positive market sentiment. The price at the end of the year is forecast at 1196.

Aarti Pharmalabs share price target 2026

Aarti Pharmalabs has over 200 product lines and 56 patents filed with more than 2000 employees and 500+ global clients. The company’s global market share is 15 to 20 percent, and it exports its business to more than 50 countries. company has a strong financial presence with an A+ rating by various rating agencies. Aarti Pharmalab’s initial forecasted share value for the beginning of 2026 is 1210. The semi-annual price forecast may rise to 1268 in a positive market sentiment. The price at the end of the year is forecast at 1365.

Aarti Pharmalabs share price target 2027

As per Q4 results for 2024, revenue decreased by -4% YoY and slightly increased by 12.82% compared to the last quarter of December 2023 and expenses have moderately decreased year over year by -7% and by -9.5% quarter-on-quarter. The company made a 21,690 lakh profit in fiscal year 2024, compared to 19,389 lakhs as of March 2023. Quarter-on-quarter net profit after increased by 23%. Overall, Q4 2024, results were not good that much yet, need to look forward for Q1, 2025 results for the best financials.

Looking at these highlights, we may assume the share price target for Aarti Pharmalabs 2027 is 1400 at the beginning of the year, 1489 at the middle of the year, and 1574 at the end of the year.

Aarti Pharmalabs share price target 2028

Aarti Pharmalabs share price target for 2028 is 1610 at the start of the financial year. The price was forecast at 1666 in the middle of the year with some price consolidation for some months, and the projected share price is 1732 at the end of the year.

Aarti Pharmalabs share price target 2029

Aarti Pharmalabs price in 2029 is expected to reach 1875 to 2005, with some consolidation zones. The initial forecasted share value for the beginning of the year is 1750. The semi-annual price forecast may rise to 1875 in a positive market sentiment. The price at the end of 2029 is forecast at 1985 to 2005.

Aarti Pharmalabs share price target 2030

The initial price target of Aarti Pharmalabs is 2079 at the beginning of the year 2030. The half-yearly price forecast can rise to 2239 in a positive market situation. The price at the end of the year is forecast to 2348.

know more K.P. Energy share price target

Aarti Pharmalabs share price target 2035

Depending on company economics and sector demand and supply with a favorable trend pattern, we may assume the target price of Aarti Pharmalabs share price target of 2035 to be 4586 at the beginning of the year, 4755 at the middle of the year, and 4988 at the end of the financial year.

Conclusion

This article presents Aarti Pharmalabs share price targets 2024 to 2030 and 2035. Targets are mentioned based on technical and fundamental analysis. stock may be corrected by any news or by companies’ poor or good results. Consider it a proposed level of guidance and not a recommendation. The stock market has high risk and unpredictable moves; invest with your risk appetite and a well-researched advisory.